Lymphoma, Non-Hodgkin (NHL) Completed Phase 2 Trials for Mycophenolate mofetil (DB00688)

Also known as: Lymphomas: Non-Hodgkin / NHL / Non Hodgkin´s Lymphomas / NHL - Non-Hodgkin's Lymphoma / NHL (Non-Hodgkin Lymphoma) / Lymphoma,Non-Hodgkin / Non-Hodgkin's Disease / Lymphoma, Non-Hodgkin;Hodgkin Disease / Non Hodgkin Lymphoma / Non Hodgkin's Lymphoma / Lymphoma, Non Hodgkin / Non Hodgkin Lymphoma (NHL) / Non-Hodgkin / Non-Hodgkin's Lymphomas / Non-Hodgkin Lymphoma / Non-Hodgkin Lympoma / Non-Hodgkins Lymphoma (NHL) / Non-Hodgkin-Lymphoma / Lymphoma, Non-Hodgkin's / Non Hodgkins Lymphoma / Non-Hodgkin Lymphomas / Lymphoma, Non-Hodgkin / Non-Hodgkin's Lymphoma(NHL) / Non-Hodgkin's Lymphoma (NHL) / Lymphoma. Non-Hodgkin / Non-Hodgkin's Lymphoma / Non-Hodgkins Lymphoma / Lymphoma Non-Hodgkin / Non-Hodgkins's Lymphoma / Non-Hodgkin’s lymphoma / Lymphoma, Non-Hodgkins / Non-Hodgkins / Non-Hodgkin Lymphoma (NHL) / Non-Hodgkin's Lymphoma or Hodgkin's Disease / Lymphoma NOS / Histiocytosis X / Non-Hodgkin's lymphoma NOS / Lymphoma (non-Hodgkin's)

IndicationStatusPhase
DBCOND0032469 (Lymphoma, Non-Hodgkin (NHL))Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00185692Allogeneic Transplantation From Related Haploidentical DonorsTreatment
NCT00566696Mismatched Family Member Donor Transplantation for Children and Young Adults With High Risk Hematological MalignanciesTreatment
NCT00096161Pentostatin and Lymphocyte Infusion in Preventing Graft Rejection in Patients Who Have Undergone Donor Stem Cell TransplantTreatment
NCT01527045Donor Atorvastatin Treatment in Preventing Severe Acute GVHD After Nonmyeloablative Peripheral Blood Stem Cell Transplant in Patients With Hematological MalignanciesPrevention
NCT00350181Sirolimus and Mycophenolate Mofetil as Graft Versus Host Disease Prophylaxis in Myeloablative Matched Related Donor Hematopoietic Cell TransplantPrevention
NCT00309842Myeloablative Umbilical Cord Blood Transplantation in Hematological DiseasesTreatment
NCT00709592Reduced Intensity Total Body Irradiation + Thymoglobulin Followed by Allogeneic PBSCTTreatment
NCT00571662Safety and Efficacy of Pentostatin and Low Dose TBI With Allogenic Peripheral Blood Stem Cell TransplantTreatment